Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultrasound-guided Botulinum Toxin A for Sialorrhea After True Bulbar Palsy
NCT07070817Withdrawn
- Start
- Dec 2025
- Primary completion
- Dec 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised trial in sialorrhea comparing Botulinum Toxin Type A with Placebo (2 arms). Primary endpoint: Global Impression of Change Scale at 4 weeks. Planned start Dec 2025; status: withdrawn.
02
Drugs
botulinum toxin type A
03
Conditions
sialorrhea
Beyond the preview
Go deeper on NCT07070817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07070817.